It's a sad year! Huahai has added 10 new lawsuits in the United States, 9 of which are class actions
-
Last Update: 2018-12-24
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
On December 22, Huahai pharmaceutical issued a notice that as of October 8, 2018, the company had received 5 cases of consumer litigation in the United States due to the impact of valsartan incident For details, please refer to the notice on litigation involving the company and its subsidiaries issued by the company on October 8, 2018 At present, there is no new progress in the five cases Recently, the company received a notice from its subsidiary Huahai (USA) International Co., Ltd as of the date of this announcement, the company received 10 new lawsuits caused by valsartan events (9 of which are class lawsuits) The full text of the announcement is as follows:
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
